Development of predictive risk models for major adverse cardiovascular events among patients with type 2 diabetes mellitus using health insurance claims data

被引:0
|
作者
James B. Young
Marjolaine Gauthier-Loiselle
Robert A. Bailey
Ameur M. Manceur
Patrick Lefebvre
Morris Greenberg
Marie-Hélène Lafeuille
Mei Sheng Duh
Brahim Bookhart
Carol H. Wysham
机构
[1] Cleveland Clinic Foundation Lerner College of Medicine of Case Western Reserve University,
[2] Analysis Group,undefined
[3] Inc.,undefined
[4] Janssen Scientific Affairs,undefined
[5] LLC,undefined
[6] Analysis Group Inc.,undefined
[7] Rockwood Clinic,undefined
来源
关键词
Type 2 diabetes mellitus; Cardiovascular disease; Risk prediction; Health insurance claims;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] No Increased Risk of Cardiovascular Events with Dapagliflozin in Elderly Patients with Type 2 Diabetes Mellitus, Cardiovascular Disease, and Hypertension
    Gause-Nilsson, Ingrid Ami
    Sonesson, Christian
    Johansson, Peter A.
    Sugg, Jennifer E.
    Johnsson, Eva
    DIABETES, 2015, 64 : A4 - A4
  • [42] No increased risk of cardiovascular events with dapagliflozin in elderly patients with type 2 diabetes mellitus, cardiovascular disease and hypertension
    Gause-Nilsson, I.
    Sonesson, C.
    Johansson, P. A.
    Johnsson, E.
    DIABETOLOGIA, 2015, 58 : S362 - S363
  • [43] CANAGLIFLOZIN VERSUS SEMAGLUTIDE FOR SECONDARY PREVENTION OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS - VALUE PER MONEY ANALYSIS
    Arbel, Ronen
    Hammerman, Ariel
    Aboalhasan, Enis
    Azuri, Joseph
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 1610 - 1610
  • [44] Triglyceride-glucose related indices as predictors for major adverse cardiovascular events and overall mortality in type-2 diabetes mellitus patients
    Liu, Mao-Jun
    Pei, Jun-Yu
    Zeng, Cheng
    Xing, Ying
    Zhang, Yi-Feng
    Tang, Pei-Qi
    Deng, Si-Min
    Hu, Xin-Qun
    WORLD JOURNAL OF DIABETES, 2025, 16 (03)
  • [45] Cardiovascular risk factors in patients with type 2 diabetes mellitus
    Carolina Vintimilla, Evelin
    Vintimilla Molina, Jhojana Rosati
    Carmendel Rocio Parra
    Martinez Santander, Diana Antonieta
    Martinez Santander, Carlos Jose
    del Rocio Andrade, Neida
    Cumbe Guerrero, Karla Maria
    Cardenas Heredia, Fredy Rosendo
    REVISTA LATINOAMERICANA DE HIPERTENSION, 2018, 13 (04): : 356 - 360
  • [46] Reducing cardiovascular risk in patients with type 2 diabetes mellitus
    Nicholls, Stephen J.
    Ryden, Lars
    EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2010, 17 : S1 - S1
  • [47] Risk of major cardiovascular events in patients with type 2 diabetes with and without prior cardiovascular events: results from the LEADER trial
    Poulter, N. R.
    Bain, S. C.
    Buse, J. B.
    Monk-Hansen, T.
    Nauck, M.
    Rasmussen, S.
    Pratley, R.
    Zinman, B.
    Orsted, D.
    Marso, S. P.
    EUROPEAN HEART JOURNAL, 2017, 38 : 819 - 819
  • [48] Framingham risk and major adverse cardiovascular events among patients with hypertension ineligible for SPRINT
    Petito, Lucia
    Huang, Xiaoning
    Jefferson, Celeena
    Vupputuri, Suma
    Lancki, Nicola
    Ahmad, Faraz
    Kazi, Dhruv
    Ndumele, Chiadi
    Allen, Norrina
    Persell, Stephen
    Shah, Nilay
    Lloyd-Jones, Donald
    Khan, Sadiya
    CIRCULATION, 2024, 150
  • [49] Risk Models for the Development of Cardiovascular and Microvascular Events in Adults with Type 2 Diabetes in the FIELD Study
    Ong, Kwok Leung
    O'Connell, Rachel L.
    Januszewski, Andrzej S.
    Donoghoe, Mark W.
    Gebski, Val
    Sullivan, David
    Rye, Kerry Ann
    Scott, Russell S.
    Best, James D.
    Taskinen, Marja-Riitta
    Simes, Robert J.
    Jenkins, Alicia
    Keech, Anthony C.
    DIABETES, 2023, 72
  • [50] Positive Predictive Value (PPV) of Commercial Health Insurance Claims Data for Identifying Acute Pancreatitis (AP) in Patients with Diabetes Mellitus (DM)
    Dore, David D.
    Hoffman, Clorinda
    Quinn, Sherry G.
    Chaudhry, Saadia
    Seeger, John D.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S103 - S103